Skip to main content
logo
Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
497.35
-7.60 (-1.51%)
At close: Jan 21, 2026, 4:00 PM EST
496.97
-0.38 (-0.08%)
After-hours: Jan 21, 2026, 4:15 PM EST

Madrigal Pharmaceuticals Revenue

Madrigal Pharmaceuticals had revenue of $287.27M in the quarter ending September 30, 2025, with 362.03% growth. This brings the company's revenue in the last twelve months to $740.64M, up 864.21% year-over-year. In the year 2024, Madrigal Pharmaceuticals had annual revenue of $180.13M.

Revenue (ttm)
$740.64M
Revenue Growth
+864.21%
P/S Ratio
15.12
Revenue / Employee
$1,402,727
Employees
528
Market Cap
11.30B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024180.13M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012147.00K-7.44M-98.06%
Dec 31, 20117.58M-7.22M-48.77%
Dec 31, 201014.80M-129.44M-89.74%
Dec 31, 2009144.25M141.63M5,416.06%
Dec 31, 20082.62M--
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jazz Pharmaceuticals4.16B
BioMarin Pharmaceutical3.09B
Exelixis2.29B
Bio-Techne1.22B
Ionis Pharmaceuticals966.96M
Ascendis Pharma758.59M
Axsome Therapeutics561.26M
Avidity Biosciences20.87M
Revenue Rankings

MDGL News

More News